This site is intended for health professionals only

Interferon-b: first-line therapy in multiple sclerosis


Per Soelberg Sorensen

Danish Multiple Sclerosis Centre,

University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark

Approximately 85% of patients with multiple sclerosis (MS) have a relapsing

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine